HomeCompareBAX vs TRV

BAX vs TRV: Dividend Comparison 2026

BAX yields 2.28% · TRV yields 1.51%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRV wins by $10.6K in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
TRV
TRV
● Live price
1.51%
Share price
$291.82
Annual div
$4.40
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.2K
Annual income
$2,702.00
Full TRV calculator →

Portfolio growth — BAX vs TRV

📍 TRV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXTRV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + TRV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
TRV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
TRV
Annual income on $10K today (after 15% tax)
$128.16/yr
After 10yr DRIP, annual income (after tax)
$2,296.70/yr
At 15% tax rate, TRV beats the other by $2,287.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + TRV for your $10,000?

BAX: 50%TRV: 50%
100% TRV50/50100% BAX
Portfolio after 10yr
$25.9K
Annual income
$1,356.13/yr
Blended yield
5.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BAX right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
TRV
Analyst Ratings
1
Strong
12
Buy
27
Hold
3
Sell
Consensus: Hold
Price Target
$312.75
+7.2% upside vs current
Range: $304.00 — $317.00
Altman Z
1.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
TRV buys
0
No recent congressional trades found for BAX or TRV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXTRV
Forward yield2.28%1.51%
Annual dividend / share$0.36$4.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%28.6%
Portfolio after 10y$20.6K$31.2K
Annual income after 10y$10.26$2,702.00
Total dividends collected$602.00$9.7K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusHoldHold
Analyst price target$19.75$312.75

Year-by-year: BAX vs TRV ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrTRV PortfolioTRV Income/yrGap
1← crossover$10,866$166.33$10,894$193.90$28.00TRV
2$11,750$123.31$11,910$253.87$160.00TRV
3$12,664$90.97$13,078$333.59$414.00TRV
4$13,617$66.89$14,433$440.23$816.00TRV
5$14,619$49.07$16,028$583.95$1.4KTRV
6$15,679$35.94$17,929$779.35$2.3KTRV
7$16,802$26.30$20,232$1,047.79$3.4KTRV
8$17,998$19.23$23,069$1,421.06$5.1KTRV
9$19,272$14.05$26,631$1,947.44$7.4KTRV
10$20,631$10.26$31,197$2,702.00$10.6KTRV

BAX vs TRV: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

TRVFinancials

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United states and internationally. The company operates through three segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment offers workers' compensation, commercial automobile and property, general liability, commercial multi-peril, employers' liability, public and product liability, professional indemnity, marine, aviation, onshore and offshore energy, construction, terrorism, personal accident, and kidnap and ransom insurance products. This segment operates through select accounts, which serve small businesses; commercial accounts that serve mid-sized businesses; national accounts, which serve large companies; and national property and other that serve large and mid-sized customers, commercial trucking industry, and agricultural businesses, as well as markets and distributes its products through brokers, wholesale agents, and program managers. The Bond & Specialty Insurance segment provides surety, fidelity, management and professional liability, and other property and casualty coverages and related risk management services through independent agencies and brokers. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners insurance to individuals through independent agencies and brokers. The Travelers Companies, Inc. was founded in 1853 and is based in New York, New York.

Full TRV Calculator →
📬

Get this BAX vs TRV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.